This presentation will identify the challenges in the provision of medicines information in pregnancy and breastfeeding with a key focus on COVID-19 and the novel therapies approved by the TGA.
Learning Objectives:
- Identify principles used in evaluating the safety of medicine use in pregnancy and breastfeeding
- Evaluate the safety of various medicines in pregnant and breastfeeding patients
- Describe the complexities of medicine use in these patients
- Assess the safety and impact of new COVID-19 therapies over the perinatal period